Compare Merck & Co., Inc. (MRK) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Merck & Co., Inc. trades at $125.97 (market cap $307.25B), while State Street Real Estate Select Sector SPDR ETF trades at $45.21. The key difference: Merck & Co., Inc. pays a 2.73% dividend while State Street Real Estate Select Sector SPDR ETF pays none. Which is the better fit depends on your goals.
| MRK | XLRE | |
|---|---|---|
Market Cap | $307.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $129.52 | $45.46 |
52-Week Low | $77.60 | $40.01 |
Enterprise Value | $350.66B | — |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
